Glaxosmithkline Llc Pac (Gsk Pac) NOV MONTHLY Filings
| Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
|---|---|---|---|---|---|---|
| 2024 | Nov. 7, 2023 | Oct. 31, 2023 | $24,142.91 | $9,582.36 | $16,160.94 | |
| 2022 | Nov. 17, 2021 | Oct. 31, 2021 | $25,348.49 | -$2,416.14 | $116,042.64 | |
| 2020 | Nov. 7, 2019 | Oct. 31, 2019 | $24,868.49 | $5,397.57 | $161,046.48 | |
| 2018 | Nov. 20, 2017 | Oct. 31, 2017 | $33,128.86 | $6,571.97 | $67,479.25 | |
| 2016 | Nov. 19, 2015 | Oct. 31, 2015 | $30,981.60 | $7,061.81 | $131,962.41 | |
| 2014 | Nov. 20, 2013 | Oct. 31, 2013 | $41,714.95 | $31,690.23 | $67,615.51 | |
| 2012 | Nov. 18, 2011 | Oct. 31, 2011 | $43,450.20 | $44,569.44 | $51,460.67 | |
| 2010 | Nov. 19, 2009 | Oct. 31, 2009 | $96,170.05 | $139,774.00 | $258,021.41 | |
| 2008 | Sept. 18, 2009 | Oct. 31, 2007 | Compare to original | $77,525.20 | $75,200.00 | $194,179.00 |
| 2006 | Nov. 29, 2005 | Oct. 31, 2005 | Compare to original | $81,566.00 | $120,175.00 | $394,821.00 |
| 2004 | Nov. 14, 2003 | Oct. 31, 2003 | $74,767.80 | $56,596.70 | $231,238.00 | |
| 2002 | Nov. 19, 2001 | Oct. 31, 2001 | View | View |